Match tier Listed
Presence Current · Arkansas
Last published 2024
Sources OpenAlex · ORCID
Refreshed 2026-08-06

Alaina Burns

Researcher

Graduate Student Researcher

1 h-index 1 pubs 2 cited

  • Chromones
  • Morpholines
  • Solubility
  • Protein Kinase Inhibitors
  • DNA-Activated Protein Kinase
  • DNA Damage
  • Humans
  • T-Lymphocytes
  • Cell Line, Tumor

Biography and Research Information

OverviewAI-generated summary

Alaina Burns, a graduate student at the University of Arkansas for Medical Sciences, investigates the development of novel therapeutic compounds. Her recent publication focuses on the discovery of DA-143, a DNA-PKcs inhibitor designed with enhanced solubility compared to existing compounds like NU7441. This research explores potential applications in treating conditions involving DNA damage, particularly within T-lymphocytes and tumor cell lines. Burns collaborates with researchers including Randall R Rainwater, Brendan Frett, Ana Clara P. Azevedo‐Pouly, and Baku Acharya, all affiliated with the University of Arkansas for Medical Sciences. Her scholarly work to date includes one publication and has garnered one citation, with an h-index of 1.

Metrics

  • h-index: 1
  • Publications: 1
  • Citations: 2

Selected Publications

  • Discovery of the DNA-PKcs inhibitor DA-143 which exhibits enhanced solubility relative to NU7441 (2024)
    2 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

11 Collaborators 4 Institutions 2 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics